Market Overview:
The global plaquenil drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of arthritis, lupus erythematosus, and COVID-19, and the rising demand for plaquenil drugs in emerging economies. The global plaquenil drugs market is segmented on the basis of type into tablet and injection. The tablet segment is expected to account for a larger share of the global plaquenil drugs market than the injection segment during the forecast period. This can be attributed to factors such as ease of use and lower cost as compared with injections. On the basis of application, the global plaquenil drugs market is divided into arthritis, lupus erythematosus, COVID-19, and others (including psoriasis, ankylosing spondylitis). Arthritis accounted for a major share of this market in 2017 owing to its high prevalence across all regions globally. However, COVID-19 is expected to grow at a higher CAGR during 2018–2030 due its growing incidence worldwide.
Product Definition:
Plaquenil is an older drug that is used to treat malaria. It is also effective for treating lupus erythematosus and rheumatoid arthritis.
Tablet:
Tablet is a form of oral solid dosage drug delivery systems that comes in sizes from 4cm to 12 cm and has the ability to hold around 100 mg to 1 g of medicine. It's major application is in the field of pharmaceuticals, where it acts as a carrier for active ingredients. The tablet can be divided into two categories: film and enteric coated tablets.
Injection:
Injection is the most common form of drug delivery used in pharmaceuticals. It has been observed that injections are more popular among patients as compared to other forms such as tablets and oral formulations. This can be attributed to several advantages associated with it such as quick absorption, immediate effect, and high concentration availability at a fixed time interval.
Application Insights:
Plaquenil is used for the treatment of arthritis, lupus erythematosus, and other diseases. The arthritis segment held the largest share in 2017 owing to high product usage for pain management in patients suffering from rheumatoid arthritis. It also has a high success rate as an anti-inflammatory drug and is therefore highly preferred by doctors across the globe.
The others application segment includes use of plaquenil during pregnancy, influenza infections, bacterial or viral pneumonia among others. The drug is widely used during pregnancy due to its benefits on multiple levels such as improving metabolism thus increasing energy levels in mothers and babies; reducing blood pressure; decreasing stress hormones that can lead to preterm birth; reducing risk of heart disease & stroke among mother & baby through improved blood flow to baby¢â‚¬â„¢s brain etcetera.
Regional Analysis:
North America held the largest revenue share of over 40% in 2017. The region is expected to maintain its dominance throughout the forecast period owing to high disease prevalence, quick adoption of technologically advanced products and increasing healthcare expenditure. Moreover, presence of major market players such as Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co., Inc.; and Abbott will also help maintain its dominance during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years due to factors such as improving economic conditions, growing population base with rising disposable income levels, and rapid urbanization resulting in increased demand for medical services leading to an increase in healthcare expenditure by government agencies and private companies which will boost industry growth.
Growth Factors:
- Increasing prevalence of autoimmune diseases: The global Plaquenil Drugs market is expected to benefit from the increasing prevalence of autoimmune diseases. This is because Plaquenil Drugs are used for the treatment of such diseases.
- Rising awareness about the benefits of Plaquenil Drugs: There is a rising awareness among people about the benefits of using Plaquenil Drugs for treating various medical conditions. This is likely to drive demand for these drugs in the coming years.
- Technological advancements in drug delivery systems: The global Plaquenil Drugs market is expected to benefit from technological advancements in drug delivery systems, which will help improve patient compliance and uptake rates for these drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Plaquenil Drugs Market Research Report
By Type
Tablet, Injection
By Application
Arthritis, Lupus Erythematosus, COVID-19, Others
By Companies
Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma, Sun Pharma, Kyung Poong, Ipca Laboratories, Hanlim Pharmaceutical, Bristol Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Plaquenil Drugs Market Report Segments:
The global Plaquenil Drugs market is segmented on the basis of:
Types
Tablet, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arthritis, Lupus Erythematosus, COVID-19, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Novartis
- Shanghai Zhongxisanwei
- Teva
- Zydus Cadila
- Mylan
- Apotex
- Advanz Pharma
- Sun Pharma
- Kyung Poong
- Ipca Laboratories
- Hanlim Pharmaceutical
- Bristol Laboratories
Highlights of The Plaquenil Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Injection
- By Application:
- Arthritis
- Lupus Erythematosus
- COVID-19
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plaquenil Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Plaquenil is an anti-epileptic drug that is used to treat seizures. It works by reducing the number of seizures a person has.
Some of the major players in the plaquenil drugs market are Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma, Sun Pharma, Kyung Poong, Ipca Laboratories, Hanlim Pharmaceutical, Bristol Laboratories.
The plaquenil drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plaquenil Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plaquenil Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plaquenil Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plaquenil Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plaquenil Drugs Market Size & Forecast, 2018-2028
4.5.1 Plaquenil Drugs Market Size and Y-o-Y Growth
4.5.2 Plaquenil Drugs Market Absolute $ Opportunity
Chapter 5 Global Plaquenil Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Plaquenil Drugs Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Plaquenil Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Plaquenil Drugs Market Size Forecast by Applications
6.2.1 Arthritis
6.2.2 Lupus Erythematosus
6.2.3 COVID-19
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plaquenil Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plaquenil Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Plaquenil Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Plaquenil Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Plaquenil Drugs Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Plaquenil Drugs Market Size Forecast by Applications
9.10.1 Arthritis
9.10.2 Lupus Erythematosus
9.10.3 COVID-19
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Plaquenil Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Plaquenil Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Plaquenil Drugs Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Plaquenil Drugs Market Size Forecast by Applications
10.10.1 Arthritis
10.10.2 Lupus Erythematosus
10.10.3 COVID-19
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Plaquenil Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Plaquenil Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Plaquenil Drugs Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Plaquenil Drugs Market Size Forecast by Applications
11.10.1 Arthritis
11.10.2 Lupus Erythematosus
11.10.3 COVID-19
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Plaquenil Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Plaquenil Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Plaquenil Drugs Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Plaquenil Drugs Market Size Forecast by Applications
12.10.1 Arthritis
12.10.2 Lupus Erythematosus
12.10.3 COVID-19
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Plaquenil Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Plaquenil Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Plaquenil Drugs Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Plaquenil Drugs Market Size Forecast by Applications
13.10.1 Arthritis
13.10.2 Lupus Erythematosus
13.10.3 COVID-19
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plaquenil Drugs Market: Competitive Dashboard
14.2 Global Plaquenil Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Novartis
14.3.3 Shanghai Zhongxisanwei
14.3.4 Teva
14.3.5 Zydus Cadila
14.3.6 Mylan
14.3.7 Apotex
14.3.8 Advanz Pharma
14.3.9 Sun Pharma
14.3.10 Kyung Poong
14.3.11 Ipca Laboratories
14.3.12 Hanlim Pharmaceutical
14.3.13 Bristol Laboratories
